INS and metabolic dysfunction-associated steatotic liver disease: Liver diseases such as non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH) are characterized by excess hepatic accumulation of lipid droplets and triglycerides which are associated with defective insulin action.